Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Community sentiment
Where do you think ODTX is heading?
Keep private notes on ODTX — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
ODTX vs S&P 500 · rebased to 100
Background shading marks the US business-cycle phase at each point in time — early, mid and late expansion, then recession— so you can see which economic backdrop each move happened in. Recessions are NBER-official; expansion sub-phases are ActaClear's editorial dating.
Live market
delayed ≤15 min- Market cap
- $867.7M
- Enterprise value
- $867.7M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $20.30
- 52-wk low
- $15.35
- Beta
- —
- Shares out
- 48.0M
What this company does
Not yet available for ODTX.
Key risks
Not yet available for ODTX.
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Biological Products, (No Diagnostic Substances) (166 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 27, 2026.